Another similar drug imatinib has shown promise in treating rheumatoid arthritis in mouse models [25] and specific patients [26], [27], speculated due to its inhibition of mast cell c-Kit and PDGFRB. This evidence concerns the gene KIT and rheumatoid arthritis.